Q4FY16 Results: Sanofi India
Bhagyashree Vivarekar / 27 Feb 2017
The company reported sales of Rs 592 crore for Q4FY16, which represents a 5.13 per cent sequential decline and 4.1 per cent YoY increase.
Sanofi India Ltd. reported its standalone results for the quarter ended December 31, 2016 today.
The company reported sales of Rs 592 crore for Q4FY16, which represents a 5.13 per cent sequential decline and 4.1 per cent YoY increase.
Its operating profit (EBIT) for the quarter amounted was Rs. 66.1 crore and its EBIT margin stood at 11.17 per cent.
The company reported PAT of Rs 50.5 crore, which represents a sequential QoQ decline of 37.34 per cent and a YoY decline of 3.81 per cent.
The company's stock opened at Rs 4138.65 on the BSE, rose 0.46 per cent and closed for the day at Rs 4157.85.
Sanofi Inida Ltd. is an Indian pharmaceutical company. The company's product portfolio includes medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.